Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function
Michael S. Chen, MD*,
Nassir F. Marrouche, MD*,
Yaariv Khaykin, MD*,
A. Marc Gillinov, MD*,
Oussama Wazni, MD*,
David O. Martin, MD, MPH*,
Antonio Rossillo, MD*,
Atul Verma, MD*,
Jennifer Cummings, MD*,
Demet Erciyes, MD*,
Eduardo Saad, MD*,
Mandeep Bhargava, MD*,
Dianna Bash, RN*,
Robert Schweikert, MD*,
David Burkhardt, MD*,
Michelle Williams-Andrews, RN*,
Alejandro Perez-Lugones, MD*,
Ahmad Abdul-Karim, MD*,
Walid Saliba, MD* and
Andrea Natale, MD*,*
* Center for Atrial Fibrillation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
View larger version (18K):
[in a new window]
|
Figure 1 Kaplan-Meier analysis of our subjects. Freedom from atrial fibrillation (AF) after pulmonary vein isolation in patients with normal (solid line) and impaired (dashed line) left ventricular (LV) function (p < 0.04).
|
|
View larger version (23K):
[in a new window]
|
Figure 2 Changes in left ventricular ejection fraction before versus after pulmonary vein isolation (PVI) for each individual patient with impaired ejection fraction.
|
|
|
